42563-53-1

4H-1,3-Oxazine, 5,6-dihydro-4-(2-methoxyethyl)-6-methyl-

3-Furancarbonitrile,2-amino-5-(4-chlorophenyl)-4,5-dihydro-4,4-diphenyl-

3-Furancarboxamide,N-[cis-4-[(7-chloro-4-quinolinyl)amino]cyclohexyl]-2,5-dimethyl-

4(3H)-Quinazolinone,7-methoxy-2-methyl-3-[4-[3-(1-pyrrolidinyl)propoxy]phenyl]-

3-Furancarboxamide,5-[(2,5-dihydro-4-hydroxy-1-methyl-5-oxo-1H-pyrrol-3-yl)carbonyl]-N-ethyl-2-[(4-fluorophenyl)methyl]-

4(3H)-Quinazolinone,7-chloro-3-[4-[(1-cyclopentyl-4-piperidinyl)oxy]phenyl]-2-methyl-

3-Furanmethanol, 2-methyl-5-[3-(trifluoromethyl)phenyl]-

3-Furancarboxylic acid, 2,5-dihydro-2-oxo-5-(phenylmethylene)-, (Z)-

3-Furanol, tetrahydro-4,4-dimethyl-

3-Furanpropanoic acid, 2-methyl-5-[4-(trifluoromethyl)phenyl]-

3-Furancarboxylic acid, 2-(3-butenyl)-4,5-dihydro-5-(1-iodoethyl)-, ethylester

3-Furancarboxamide,N-[3-cyano-4-[(2-thienylmethyl)amino]-2-quinolinyl]-

3-Furancarbonitrile,4-(4-methoxyphenyl)-2-phenyl-5-[(phenylmethylene)amino]-

1-{hydroxy[bis(2-methoxyphenyl)]methyl}cyclopentanol

3-Furancarboxamide, 2,5-dimethyl-N-(2-methyl-5-benzothiazolyl)-

3-Furancarboxylic acid, 2,3-dihydro-3-methyl-2-phenyl-,(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester, (2S,3S)-

Alanine,3-chloro-N-[(1,1-dimethylethoxy)carbonyl]-3,3-difluoro-2-hydroxy-,methyl ester

3-Furancarboxamide, 5-[(1R)-1-aminopropyl]-N,N,2-trimethyl-

3-Furancarboxamide,N-[3-cyano-4-[(2-furanylmethyl)amino]-2-quinolinyl]-

3H-1,2,3-Triazolo[4,5-d]pyrimidin-5-amine,7-chloro-3-[(2-chloro-3,5-dimethoxyphenyl)methyl]-

3H-1,2,3-Dithiazolo[4,5-b]quinoxalin-3-yl, 7-chloro-

3-Furancarboxylic acid, 1-methyl-4-piperidinyl ester,(2Z)-2-butenedioate (1:1)

3-Furancarboxylic acid,4-ethenyltetrahydro-2-hydroxy-4-methyl-2-(phenylmethyl)-, ethyl ester,(4S)-

3-Furancarbonitrile,2-amino-4,5-dihydro-5-methyl-4,4-bis(4-methylphenyl)-5-pentyl-

3-Furanheptanoic acid, 4-formyl-, methyl ester

3-Furanheptanoic acid, 2,5-dihydro-2-oxo-, methyl ester

3-Furancarboxylic acid,tetrahydro-2-(3-methoxyphenyl)-2-methyl-5-oxo-, ethyl ester,(2R,3R)-rel-

3-Furancarboxamide, N-(5-chloro-2-methoxyphenyl)-2,5-dihydro-5-oxo-

3H,7H-Oxazolo[3,4-a][1,3]diazepine-9-carbothioamide,2,4,5,9-tetrahydro-9-methyl-N-phenyl-7-thioxo-

3-Furanmethanaminium, N,N,N-trimethyl-, iodide

3H,6H-Furo[3,4-c]isoxazol-6-one, tetrahydro-4-methyl-6a-phenyl-

2-(4-Aminophenyl)-N,N-dimethylacetamide

3-Furanethanol, a-(4-methylphenyl)-

6,10-Octadecadiene, (6E,10E)-

3-Furancarboxamide,N-[(1S)-1-[3-[(3,4,5-trimethoxyphenyl)amino]-1,2,4-triazin-6-yl]ethyl]-

3-Furancarboxylic acid, 2-(4-methylphenyl)-5-phenyl-, methyl ester

Azacyclooctadec-11-en-2-one

42563-53-1 msds

CAS No 42563-53-1 supplier

CASNo 42563-53-1 distributor

CAS # 42563-53-1 manufacturer

CAS Number 42563-53-1 safety

CAS RN 42563-53-1 wholesale

2026-10-14 Find 4H-1,3-Oxazine, 5,6-dihydro-4-(2-methoxyethyl)-6-methyl-,CAS No.42563-53-1,Formula:C8H15NO2 in ChemGloble